Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Stanford University

Palo Alto, California, United States, 94304

Contact: Eliana A Frank       elianaf@stanford.edu   

Principal Investigator: Rayhan Lal, MD         

Rady Children’s Hospital San Diego

San Diego, California, United States, 92123

Contact: Marla Hashiguchi       mhashiguchi@rchsd.org   

Principal Investigator: Carla Demeterco-Berggren, MD         

Barbara Davis Center for Childhood Diabetes

Aurora, Colorado, United States, 80045

Contact: Estella Escobar       estella.escobar@cuanschutz.edu   

Principal Investigator: Gregory Forlenza, MD         

Barbara Davis Center

Aurora, Colorado, United States, 80045

Contact: Ashleigh Downs       ashleigh.downs@cuanschutz.edu   

Principal Investigator: Halis Kaan Akturk, MD         

Yale University

New Haven, Connecticut, United States, 06511

Contact: Lori Carria       lori.carria@yale.edu   

Principal Investigator: Laura Nally, MD         

East Coast Institute for Research (Memorial Hospital)

Jacksonville, Florida, United States, 32204

Contact: Matt Taddeo       matt.taddeo@eastcoastresearch.net   

Principal Investigator: David Sutton, MD         

University of South Florida Diabetes Center

Tampa, Florida, United States, 33612

Contact: Janet Rodriguez       janetrodriguez@health.usf.edu   

Principal Investigator: Dorothy Shulman, MD         

Atlanta Diabetes

Atlanta, Georgia, United States, 30318

Contact: Anna Busby       abusby@atlantadiabetes.com   

Principal Investigator: Bruce Bode, MD         

East Coast Institute for Research – Macon

Macon, Georgia, United States, 31210

Contact: Alicia Green       alicia.green@eastcoastresearch.net   

Principal Investigator: Thomas Jones, MD         

Endocrine Research Solutions

Roswell, Georgia, United States, 30076

Contact: Jessica Tapia       jtapia.ers@gmail.com   

Principal Investigator: John Reed, MD         

Rocky Mountain

Idaho Falls, Idaho, United States, 83404

Contact: Kelsie Landon       kelsie.landon@idahomed.com   

Principal Investigator: David Liljenquist, MD         

Mayo Clinic

Rochester, Minnesota, United States, 55905

Contact: Shelly McCrady-Spitzer       McCradySpitzer.Shelly@mayo.edu   

Principal Investigator: Yogish Kudva, MD         

International Diabetes Center

Saint Louis Park, Minnesota, United States, 55416

Contact: Wanda Konerza       wanda.konerza@parknicollet.com   

Principal Investigator: Richard Bergenstal, MD         

Physicians East

Greenville, North Carolina, United States, 27834

Contact: Elizabeth Ashley Kirk       akirk@physicianseast.com   

Principal Investigator: Mark Warren, MD         


Portland, Oregon, United States, 97239

Contact: Deborah Brandigan         

Contact       branigad@ohsu.edu   

Principal Investigator: Joseph El Yousseff, MD         

Texas Diabetes

Austin, Texas, United States, 78749

Contact: Lauren Shelton       lshelton@texasdiabetes.com   

Principal Investigator: Lindsay Harrison, MD         

Diabetes and Glandular Disease Clinic, P.A

San Antonio, Texas, United States, 78229

Contact: Millicent Gordon       millicent.gordon@dgdclinic.com   

Principal Investigator: Mark Kipnes, MD         

Rainier Research

Renton, Washington, United States, 98057

Contact: Teresa Mori       tmori@rainier-research.com   

Principal Investigator: Ronald Brazg, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 6, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine